Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses

Authors:

Abstract
It is generally accepted that an effective HIV-1 vaccine should be able to induce broad-spectrum neutralizing antibodies. Since most of these antibodies require long periods of somatic maturationin vivo, several groups are developing immunogens, based on the HIV envelope protein, that require complex and lengthy immunization protocols that would be difficult to implement in the general population.
Funding Information
  • IDIBAPS (80:20 Research Grant)
  • European Union Horizon 2020 (681137-EAVI2020)
  • Fondation Dormeur, Vaduz
  • Ministerio de Economia, Industria y Competitividad (PI17CIII/00049)
  • Ministerio de Ciencia, Innovación y Universidades (RD16CIII/0002/0001)
  • Ministerio de Ciencia, Innovación y Universidades (RD16CIII/0002/0005)
  • Ministerio de Ciencia, Innovación y Universidades (RD16/0025/0041)
  • Consejo Nacional de Innovación, Ciencia y Tecnología
  • Ministerio de Ciencia e Innovación (PI20CIII/00039)
  • HHS | National Institutes of Health (P01-AI131568)

This publication has 65 references indexed in Scilit: